Clinical Trial Update: A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety-focused study update of Selitrectinib in children and adults with NTRK fusion-positive solid tumors. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ntrk Fusion-positive Solid Tumors

Drugs mentioned

• Selitrectinib (selitrectinib)

Snippet

Sponsor: Bayer | Conditions: Solid Tumors Harboring NTRK Fusion | Phase 1 | Status: COMPLETED